Render Target: STATIC
Render Timestamp: 2024-12-20T11:19:17.618Z
Commit: f2d32940205a64f990b886d724ccee2c9935daff
XML generation date: 2024-09-30 01:59:59.972
Product last modified at: 2024-11-19T10:30:11.586Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

PDE4A (E5P9A) Rabbit mAb #82108

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 120
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    PDE4A (E5P9A) Rabbit mAb recognizes endogenous levels of total PDE4A protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu703 of human PDE4A protein.

    Background

    Phosphodiesterase (PDE) superfamily enzymes catalyze the hydrolysis of 3',5'-cyclic nucleotides into the corresponding nucleotide 5'-monophosphates. The PDE superfamily includes 11 subfamilies (PDE1-PDE11) in mammals (1). These enzymes function as important positive and negative regulators of cellular response, including regulation of insulin secretion, heart function, erectile function, and inflammation (2-5). The PDE4 subfamily consists of PDE4A, PDE4B, PDE4C, and PDE4D isoforms, and are cAMP-specific enzymes expressed in T cells, monocytes, macrophages, dendritic cells, neutrophils, and eosinophils (6). PDE4 expression is induced by epithelial damage, allergen sensitization, and microbial invasion (7). Inhibition of PDE4 subfamily members leads to the elevation of intracellular cAMP and modulates the inflammatory response (8). The isoform, PDE4A, is being investigated as a therapeutic target for various inflammatory conditions such as asthma, inflammatory bowel disease (IBD), and rheumatic arthritis (RA), and as an immune checkpoint inhibitor for multiple suppressive factors (9,10).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    KARPAS cell line source: Dr. Abraham Karpas at the University of Cambridge.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.